HIV perinatal transmission from high-risk HIV-positive pregnant women who have received raltegravir intensification antiretroviral treatment.
Phase of Trial: Phase II
Latest Information Update: 30 Aug 2017
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 30 Aug 2017 New trial record
- 26 Jul 2017 Results (n=57 ; from January to December 2016) presented at the 9th International AIDS Society Conference on HIV Science.